✦ LIBER ✦

284 Treatment of patients with carcinoma of the prostate with the gonadotropin-releasing hormone analogue Buserelin

✍ Scribed by U.K. Wenderoth; G.H. Jacobi

Book ID: 116003736
Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 92 KB
Volume: 19
Category: Article
ISSN: 0022-4731
DOI: 10.1016/0022-4731(83)91784-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Advanced Prostatic Cancer w

Treatment of Advanced Prostatic Cancer with Buserelin, an Analogue of Gonadotrophin Releasing Hormone

✍ J. H. WAXMAN; J. A. H. WASS; W. F. HENDRY; H. N. WHITFIELD; P. BARY; G. M. BESSE 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB

Failure of a gonadotropin-releasing horm

Failure of a gonadotropin-releasing hormone analogue to lower serum testosterone in patients with prostate cancer

✍ Tadashi Matsuda; Yoshihito Hiura; Naoki Oguchi; Koei Muguruma; Takashi Murota; M 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Increasing use of gonadotropin-releasing

Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma

✍ Vahakn B. Shahinian; Yong-fang Kuo; Jean L. Freeman; Eduardo Orihuela; James S. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 1 views

Steroid sulfates in testis tissue of pro

Steroid sulfates in testis tissue of prostatic cancer patients treated for six months with the gonadotropin releasing hormone agonist buserelin

✍ I. Huhtaniemi; S. Rannikko; M. Orava; R. Vihko 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 363 KB

The Effects of Gonadotropin Releasing Ho

The Effects of Gonadotropin Releasing Hormone Analogue Therapy on Girls with Gonadotropin-dependent Precocious Puberty

✍ Yi-Ching Tung; Jing-Sheng Lee; Wen-Yu Tsai; Pei-Hung Hsiao 📂 Article 📅 2007 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 113 KB

Bone fractures associated with luteinizi

Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma

✍ Murphy F. Townsend; W. Holt Sanders; Robert O. Northway; Sam D. Graham Jr. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Background: Luteinizing hormone-releasing hormone agonists (lhrh-a) have become an established treatment for certain patients with prostate carcinoma. lhrh-a are known to decrease bone mineral density. the purpose of this study was to determine the risk of bone fracture in men receiving lhrh-a f